3.4.21.46	-	36592	
3.4.21.46	crystal structure of profactor D	36585	
3.4.21.46	in complex with inhibitors, sitting drop vapor diffusion method, using 25% (w/v) PEGME 3350, 100 mM Bis-Tris pH 5.5 or 30% (w/v) PEG MME 2000, 0.1 M thiocyanate	754401	
3.4.21.46	in complex with inhibitors, vapor diffusion method, using 22 or 27% (w/v) PEG3350, 50 mM NaCl and 100 mM HEPES/NaOH, pH 7.5 at 20°C	754391	
3.4.21.46	purified enzyme in complex with anti-factor D Fab fragment, sitting drop vapor diffusion method, 20 mg/ml protein in 20 mM HEPES, pH 7.2, and 200 mM NaCl, is mixed with an equal volume of crystallization buffer containing 0.1 M MES, pH 6.5, 25% PEG monomethyl ether 550, 0.01 M zinc sulfate, and 3% 6-aminohexanoic acid, 1 day, 19°C, X-ray diffraction structure determination and analysis at 2.3 A resolution	732044	
3.4.21.46	purified enzyme in complex with anti-factor D Fab fragment, sitting drop vapor diffusion method, 30 mg/ml protein in 20 mM HEPES, pH 7.2, and 200 mM NaCl, is mixed with an equal volume of crystallization buffer containing 0.1 M Tris-HCl, pH 8.5, 0.2 M ammonium phosphate, 50% 2-methyl-2,4-pentanediol, and 0.01 M hexamine cobalt(III) chloride, 6 days, 4°C, X-ray diffraction structure determination and analysis at 2.4 A resolution	732044	
3.4.21.46	S183A mutant protein in complex with pro-convertase C3bB	718398	
3.4.21.46	structure of diisopropyl fluorophosphate-inhibited factor D	36588	
3.4.21.46	structure of native factor D and a complex formed with isatoic anhydride inhibitor	36589	
3.4.21.46	wild type and mutant factor D, expression in CHO cells	36587